Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Prevalence and covariates of electrocardiographic left ventricular hypertrophy in the Hypertension in the Very Elderly Trial.

Antikainen RL, Beckett N, Peters R, Fagard R, Rajkumar C, Wang J, Stoyanovsky V, Barrowdale D, Bulpitt CJ; HYVET Study Group..

J Hypertens. 2013 Jun;31(6):1224-32. doi: 10.1097/HJH.0b013e32836040a4.

PMID:
23588194
2.

Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.

Okin PM.

J Electrocardiol. 2009 Nov-Dec;42(6):584-8. doi: 10.1016/j.jelectrocard.2009.06.020. Epub 2009 Jul 24.

PMID:
19631946
3.

Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.

Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.

Clin Exp Hypertens. 2010 May;32(3):145-53. doi: 10.3109/10641960903254455.

PMID:
20504121
4.

T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension.

Assanelli D, Di Castelnuovo A, Rago L, Badilini F, Vinetti G, Gianfagna F, Salvetti M, Zito F, Donati MB, de Gaetano G, Iacoviello L; Moli-sani Project Investigators..

J Electrocardiol. 2013 Nov-Dec;46(6):487-91. doi: 10.1016/j.jelectrocard.2013.08.002. Epub 2013 Sep 6.

PMID:
24011993
5.

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahlöf B, Devereux RB.

Am J Hypertens. 2002 Aug;15(8):663-71.

PMID:
12160187
6.

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B; Losartan Intervention for Endpoint reduction in hypertension Study Investigations..

Circulation. 2003 Aug 12;108(6):684-90. Epub 2003 Jul 28.

7.

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.

Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B; LIFE Study Investigators..

Circulation. 2006 Mar 28;113(12):1588-96. Epub 2006 Mar 13.

8.

The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.

Antikainen R, Grodzicki T, Palmer AJ, Beevers DG, Coles EC, Webster J, Bulpitt CJ.

J Hum Hypertens. 2003 Mar;17(3):159-64.

PMID:
12624605
9.

Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.

Lutale JJ, Thordarson H, Gulam-Abbas Z, Vetvik K, Gerdts E.

Cardiovasc J Afr. 2008 Jan-Feb;19(1):8-14.

10.

Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.

Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.

Ethn Dis. 2005 Autumn;15(4):578-84.

PMID:
16259479
11.

[Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].

González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J; for Investigators study VIIDA..

Rev Esp Cardiol. 2007 Feb;60(2):148-56. Spanish.

12.

Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.

Bruno G, Giunti S, Bargero G, Ferrero S, Pagano G, Perin PC.

Diabet Med. 2004 Aug;21(8):823-8.

PMID:
15270784
13.

Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.

Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.

J Hypertens. 2007 May;25(5):1079-85.

PMID:
17414673
14.

Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.

Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C.

J Am Coll Cardiol. 1998 Feb;31(2):383-90.

15.

Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population.

Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, Pickering TG, Shimada K, Kario K; Jichi Medical School Cohort Study Investigators Group..

Hypertension. 2009 Jan;53(1):28-34. doi: 10.1161/HYPERTENSIONAHA.108.118026. Epub 2008 Nov 17.

16.

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.

Wachtell K, Olsen MH, Dahlöf B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H.

J Hypertens. 2002 Mar;20(3):405-12.

PMID:
11875307
17.

Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Antikainen RL, Peters R, Beckett NS, Fagard RH, Wang JG, Rajkumar C, Bulpitt CJ.

J Hypertens. 2016 Nov;34(11):2280-6. doi: 10.1097/HJH.0000000000001073.

PMID:
27552643
18.

Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.

Vernooij JW, Cramer MJ, Visseren FL, Korndewal MJ, Bots ML, Meijs MF, Doevendans PA, Spiering W; Smart Study Group..

Am J Cardiol. 2012 Jul 15;110(2):227-33. doi: 10.1016/j.amjcard.2012.03.016. Epub 2012 Apr 5.

PMID:
22483385
19.

Gender differences in the diagnosis and treatment of left ventricular hypertrophy detected by different electrocardiographic criteria. Findings from the SARA study.

Barrios V, Escobar C, Calderón A, Barrios S, Navarro-Cid J, Ferrer E, Echarri R.

Heart Vessels. 2010 Jan;25(1):51-6. doi: 10.1007/s00380-009-1154-1. Epub 2010 Jan 21.

PMID:
20091399
20.

Electrocardiographic criteria of left ventricular hypertrophy in general population.

Casiglia E, Schiavon L, Tikhonoff V, Bascelli A, Martini B, Mazza A, Caffi S, D'Este D, Bagato F, Bolzon M, Guidotti F, Haxhi Nasto H, Saugo M, Guglielmi F, Pessina AC.

Eur J Epidemiol. 2008;23(4):261-71. doi: 10.1007/s10654-008-9234-6. Epub 2008 Mar 6.

PMID:
18322806

Supplemental Content

Support Center